December 24, 2024 - 06:14

Former White House communications director Anthony Scaramucci recently advised tech mogul Elon Musk to steer clear of political involvement and concentrate on his thriving enterprises. During a public appearance, Scaramucci emphasized the importance of maintaining a clear focus on business, suggesting that Musk's ventures, including Tesla and SpaceX, have already achieved remarkable success.
Scaramucci expressed concern that engaging in political matters could pose risks to Musk's reputation and business interests. He warned that the political landscape is fraught with challenges and that individuals in that arena can be unpredictable and potentially damaging. By diverting his attention to politics, Musk may jeopardize the momentum he has built in the business world.
The advice comes amid Musk's increasing visibility in political discussions, where he has made headlines for his controversial statements and actions. Scaramucci's comments serve as a reminder of the potential pitfalls of mixing business with politics, urging Musk to prioritize his entrepreneurial endeavors for continued success.
May 7, 2026 - 01:03
AirAsia CEO on optimizing its fleet with record Airbus dealTony Fernandes, the CEO of Capital A, the parent company of AirAsia, has shed light on the airline`s massive new aircraft order with Airbus, calling it a strategic move to optimize operations and...
May 6, 2026 - 21:16
Frisco to welcome international visitors for FIFA World CupThe city of Frisco is set to host the Swedish national team as they prepare for the FIFA World Cup this summer. The team will use Toyota Stadium as their official training base, bringing...
May 6, 2026 - 01:10
Short vacations made her feel worse; monthlong working holidays helpedMaria Laposata learned the hard way that a standard two-week vacation did not work for her. Instead of returning refreshed, she found herself dreading the moment she would have to open her work...
May 5, 2026 - 23:20
First patient enrolled in massive heart failure trialA major clinical trial that could change the treatment landscape for millions of heart failure patients has officially begun, with the first participant now enrolled. The study, known as BENEFIT-HF...